PageOverview.com
 

Websites, domains, hosts that links to pi.amgen.com

Our database shows, that the website pi.amgen.com is linked by a total of 21 websites.

 
Number of websites/domains displayed: 21
Results found: 21
 

Websites discovered:

Enbrel® (etanercept)
http://pageoverview.com/website-report/enbrel.com
Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.
  • Expected expiration: February 11th in 2018
  • Creation date: February 11th in 1999
  • Renew date: January 10th in 2017
  • Google Analytics: 70400828-1
KYPROLIS® (carfilzomib) for Relapsed Multiple Myeloma Treatment
http://pageoverview.com/website-report/kyprolis.com
KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.
  • Expected expiration: May 11th in 2017
  • Creation date: May 11th in 2010
  • Renew date: November 10th in 2015
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCP
http://pageoverview.com/website-report/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
  • Expected expiration: October 5th in 2018
  • Creation date: October 5th in 2005
  • Renew date: September 3rd in 2017
IMLYGIC® (talimogene laherparepvec) Oncolytic Viral Therapy
http://pageoverview.com/website-report/imlygic.com
Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.
  • Expected expiration: March 29th in 2018
  • Creation date: March 29th in 2012
  • Renew date: February 25th in 2017
Amgen UA
http://pageoverview.com/website-report/amgenual.com
  • Expected expiration: May 26th in 2018
  • Creation date: May 26th in 2016
  • Renew date: May 26th in 2016
Welcome to Amgen
http://pageoverview.com/website-report/amgenfirststep.com
  • Expected expiration: October 22nd in 2018
  • Creation date: October 22nd in 2010
  • Renew date: September 21st in 2017
aranesp.com
http://pageoverview.com/website-report/aranesp.com
  • Expected expiration: September 13th in 2017
  • Creation date: September 13th in 1999
  • Renew date: August 12th in 2016
Enbrel® (etanercept) - ¡Próximamente!
http://pageoverview.com/website-report/enbrelenespanol.com
Use the Enbrel® (etanercept) site map to find the page you're looking for on Enbrel.com.
  • Expected expiration: June 26th in 2018
  • Creation date: June 26th in 2006
  • Renew date: May 25th in 2017
Repatha® (evolocumab) Official HCP Site | Repatha® (evolocumab)
http://pageoverview.com/website-report/repathahcp.com
Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.
  • Expected expiration: February 4th in 2023
  • Creation date: February 4th in 2015
  • Renew date: January 3rd in 2018
For the Treatment of Postmenopausal Osteoporosis Women at High Risk for Fracture | Prolia® (denosumab)
http://pageoverview.com/website-report/prolia.com
Learn how Prolia® (denosumab) can help in the treatment of postmenopausal osteoporosis for women at high risk for fracture.
  • Expected expiration: September 8th in 2017
  • Creation date: September 8th in 1999
  • Renew date: August 7th in 2016
Patients with Bone Metastases from Solid Tumors | XGEVA® (denosumab)
http://pageoverview.com/website-report/xgeva.com
Learn more about preventing serious bone problems with XGEVA® (denosumab) injections.
  • Expected expiration: June 7th in 2017
  • Creation date: June 7th in 2010
  • Renew date: May 6th in 2016
KYPROLIS® (carfilzomib) for HCPs | Relapsed or Refractory Multiple Myeloma Treatment
http://pageoverview.com/website-report/kyprolis-hcp.com
Learn about clinical trial data for KYPROLIS® (carfilzomib)—treats relapsed or refractory multiple myeloma.
  • Expected expiration: October 19th in 2018
  • Creation date: October 19th in 2015
  • Renew date: September 17th in 2017
Manage My Co-pay
http://pageoverview.com/website-report/managemycopay.com
Manage My Co-pay; Amgen managemycopay;
  • Expected expiration: September 12th in 2020
  • Creation date: September 12th in 2015
  • Renew date: January 29th in 2017
ITP Treatment - ITP (immune thrombocytopenia) & Nplate® (romiplostim)
http://pageoverview.com/website-report/nplate.com
Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.
  • Expected expiration: January 12th in 2018
  • Creation date: January 12th in 2008
  • Renew date: December 11th in 2016
www.sensiparhcp.com
http://pageoverview.com/website-report/sensiparhcp.com
  • Expected expiration: May 13th in 2019
  • Creation date: May 13th in 2009
  • Renew date: April 10th in 2012
Chronic Heart Failure | Corlanor® (ivabradine) Official Site
http://pageoverview.com/website-report/corlanor.com
Corlanor® (ivabradine) is a chronic heart failure treatment. Learn about Chronic HF symptoms and causes. Get the complete details on Corlanor® benefits and safety.
  • Expected expiration: March 5th in 2019
  • Creation date: March 5th in 2009
  • Renew date: February 1st in 2017
Neulasta® (pegfilgrastim) | G-CSF Injection
http://pageoverview.com/website-report/neulasta.com
Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.
  • Expected expiration: January 11th in 2018
  • Creation date: January 11th in 2002
  • Renew date: December 10th in 2016
EPOGEN® treatment for patients with anemia due to chronic kidney disease (CKD) | EPOGEN® (epoetin alfa)
http://pageoverview.com/website-report/epogen.com
EPOGEN® (epoetin alfa) is used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis to reduce or avoid the need for red blood cell transfusions.
  • Expected expiration: May 27th in 2018
  • Creation date: May 28th in 1998
  • Renew date: April 25th in 2017
Parsabiv™ (etelcalcetide)
http://pageoverview.com/website-report/parsabiv.com
  • Expected expiration: December 9th in 2018
  • Creation date: December 9th in 2014
  • Renew date: November 7th in 2017
High Cholesterol Treatment | Lower LDL | Repatha® (evolocumab)
http://pageoverview.com/website-report/repatha.com
Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.
  • Expected expiration: November 22nd in 2017
  • Creation date: November 22nd in 2013
  • Renew date: October 21st in 2016
NEUPOGEN® (filgrastim) | Granulocyte Colony-Stimulating Factor
http://pageoverview.com/website-report/neupogenhcp.com
Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.
  • Expected expiration: December 14th in 2018
  • Creation date: December 14th in 2012
  • Renew date: November 12th in 2017
0.0982 // 2024-04-28 02:36:29
All Rights reserved 2018 © PageOverview.com